This page shows 111 (YI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Cost discipline and working-capital release turned a thin-margin, inventory-heavy model from cash burn to self-funding in FY2024.
The move to operating break-even came without a richer gross margin: gross margin held near5.8% after5.7% , so the core economics did not suddenly become much richer. The bigger shift was overhead compression and working-capital release, with selling/admin expense cut to$9.7M from$31.6M as inventory and receivables both shrank.
Cash conversion improved faster than earnings: the company generated
The balance sheet remains creditor-funded, with liabilities exceeding assets by about
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of 111's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
111 has an operating margin of -0.0%, meaning the company retains $-0 of operating profit per $100 of revenue. This below-average margin results in a low score of 21/100, suggesting thin profitability after operating expenses. This is up from 0.0% the prior year.
111's revenue declined 9% year-over-year, from $2.0B to $1.8B. This contraction results in a growth score of 21/100.
111 has elevated debt relative to equity (D/E of -4.13), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.
111's current ratio of 1.09 is below the typical benchmark, resulting in a score of 17/100. This tight liquidity could limit financial flexibility if cash inflows slow.
111's free cash flow margin of 0.9% results in a low score of 26/100. Capital expenditures of $636K absorb a large share of operating cash flow.
111 passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.
For every $1 of reported earnings, 111 generates $-5.29 in operating cash flow ($17.0M OCF vs -$3.2M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
111 earns $-0.1 in operating income for every $1 of interest expense (-$340K vs $5.1M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
111 generated $1.8B in revenue in fiscal year 2025. This represents a decrease of 9.0% from the prior year.
111's EBITDA was $1.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 48.2% from the prior year.
111 reported -$3.2M in net income in fiscal year 2025. This represents a decrease of 13.1% from the prior year.
111 earned $-0.05 per diluted share (EPS) in fiscal year 2025. This represents an increase of 0.0% from the prior year.
Cash & Balance Sheet
111 generated $16.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 51.7% from the prior year.
111 held $73.1M in cash against $0 in long-term debt as of fiscal year 2025.
111 had 176M shares outstanding in fiscal year 2025.
Margins & Returns
111's gross margin was 5.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.0 percentage points from the prior year.
111's operating margin was -0.0% in fiscal year 2025, reflecting core business profitability. This is down 0.0 percentage points from the prior year.
111's net profit margin was -0.2% in fiscal year 2025, showing the share of revenue converted to profit. This is down 0.0 percentage points from the prior year.
Capital Allocation
111 invested $636K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 69.5% from the prior year.
YI Income Statement
| Metric | Q4'25 | Q4'24 | Q4'23 | Q4'22 | Q4'21 | Q4'20 | Q4'19 | Q4'18 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
YI Balance Sheet
| Metric | Q4'25 | Q4'24 | Q4'23 | Q4'22 | Q4'21 | Q4'20 | Q4'19 | Q4'18 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $314.6M-17.6% | $381.9M-12.2% | $435.1M-13.6% | $503.7M+2.0% | $493.6M+6.4% | $463.8M+100.5% | $231.3M+2.8% | $224.9M |
| Current Assets | $303.9M-16.3% | $363.0M-12.1% | $413.1M-11.9% | $469.2M+6.7% | $439.7M-0.1% | $440.3M+106.9% | $212.8M-2.9% | $219.2M |
| Cash & Equivalents | $73.1M+15.4% | $63.3M-25.5% | $85.0M-13.0% | $97.7M-5.9% | $103.8M-43.1% | $182.3M+118.4% | $83.5M-32.8% | $124.2M |
| Inventory | $142.8M-24.9% | $190.1M-4.9% | $199.9M-8.0% | $217.3M+23.5% | $175.9M+49.8% | $117.5M+68.2% | $69.8M+127.8% | $30.7M |
| Accounts Receivable | $37.1M-34.4% | $56.6M-25.1% | $75.6M+6.7% | $70.9M+11.7% | $63.5M+153.9% | $25.0M+166.7% | $9.4M+125.6% | $4.2M |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $415.0M-11.7% | $470.0M-9.1% | $517.3M-8.2% | $563.8M+8.2% | $520.8M+27.3% | $409.1M+240.5% | $120.1M+156.0% | $46.9M |
| Current Liabilities | $279.4M-12.9% | $320.9M-17.0% | $386.6M-2.1% | $395.1M+18.2% | $334.2M+33.8% | $249.8M+124.8% | $111.1M+142.9% | $45.7M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$100.4M-14.1% | -$88.0M-7.1% | -$82.2M-36.7% | -$60.1M-121.0% | -$27.2M-149.7% | $54.8M-50.9% | $111.6M-37.3% | $178.1M |
| Retained Earnings | -$564.9M-6.2% | -$532.1M+1.1% | -$537.9M-8.3% | -$496.8M-5.2% | -$472.3M-31.7% | -$358.6M-32.6% | -$270.5M-34.4% | -$201.3M |
YI Cash Flow Statement
| Metric | Q4'25 | Q4'24 | Q4'23 | Q4'22 | Q4'21 | Q4'20 | Q4'19 | Q4'18 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
YI Financial Ratios
| Metric | Q4'25 | Q4'24 | Q4'23 | Q4'22 | Q4'21 | Q4'20 | Q4'19 | Q4'18 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | 1.09-0.0 | 1.13+0.1 | 1.07-0.1 | 1.19-0.1 | 1.32-0.4 | 1.76-0.2 | 1.92-2.9 | 4.79 |
| Debt-to-Equity | -4.13+1.2 | -5.34+1.0 | -6.29+3.1 | -9.38+9.8 | -19.15-26.6 | 7.47+6.4 | 1.08+0.8 | 0.26 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$100.4M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Similar Companies
Frequently Asked Questions
What is 111's annual revenue?
111 (YI) reported $1.8B in total revenue for fiscal year 2025. This represents a -9.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is 111's revenue growing?
111 (YI) revenue declined by 9% year-over-year, from $2.0B to $1.8B in fiscal year 2025.
Is 111 profitable?
No, 111 (YI) reported a net income of -$3.2M in fiscal year 2025, with a net profit margin of -0.2%.
What is 111's EBITDA?
111 (YI) had EBITDA of $1.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is 111's gross margin?
111 (YI) had a gross margin of 5.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is 111's operating margin?
111 (YI) had an operating margin of -0.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is 111's net profit margin?
111 (YI) had a net profit margin of -0.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is 111's free cash flow?
111 (YI) generated $16.4M in free cash flow during fiscal year 2025. This represents a -51.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is 111's operating cash flow?
111 (YI) generated $17.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are 111's total assets?
111 (YI) had $314.6M in total assets as of fiscal year 2025, including both current and long-term assets.
What are 111's capital expenditures?
111 (YI) invested $636K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is 111's current ratio?
111 (YI) had a current ratio of 1.09 as of fiscal year 2025, which is considered adequate.
What is 111's debt-to-equity ratio?
111 (YI) had a debt-to-equity ratio of -4.13 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is 111's return on assets (ROA)?
111 (YI) had a return on assets of -1.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Why is 111's debt-to-equity ratio negative or unusual?
111 (YI) has negative shareholder equity of -$100.4M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is 111's Piotroski F-Score?
111 (YI) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are 111's earnings high quality?
111 (YI) has an earnings quality ratio of -5.29x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can 111 cover its interest payments?
111 (YI) has an interest coverage ratio of -0.1x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is 111?
111 (YI) scores 14 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.